Shows & Panels
- Accelerate and Streamline for Better Customer Service
- Ask the CIO
- The Big Data Dilemma
- Carrying On with Continuity of Operations
- Client Virtualization Solutions
- Data Protection in a Virtual World
- Expert Voices
- Federal Executive Forum
- Federal IT Challenge
- Federal Tech Talk
- Feds in the Cloud
- Health IT: A Policy Change Agent
- Improving Healthcare Outcomes through IT Policy
- IT Innovation in the New Era of Government
- Making Dollars And Sense Out of Data Center Consolidation
- Navigating the Private Cloud
- One Step to the Cloud, Two Steps Toward Innovation
- Path to FDCCI Compliance
- Take Command of Your Mobility Initiative
- Veterans in Private Sector: Making the Transition
Shows & Panels
Triaminic and Theraflu bottles recalled
Thursday - 1/31/2013, 3:22pm EST
NEW YORK (AP) - Some bottles of Triaminic and Theraflu cold and allergy syrups are being recalled because the child-resistant bottle caps may be defective.
The recall covers 142 production lots of Triaminic syrups and 41 lots of Theraflu syrups. Novartis, which produces the medicines, says the defect could allow for the removal the cap without breaking the seal on the bottle. The company says it received four reports of adverse events related to the Triaminic products.
The products were made between May 2010 and December 2011 at a Novartis facility in Nebraska. Novartis shut down that plant in December 2011 after federal inspections found numerous quality-control problems.
Novartis says it believes 97 percent of the inventory has been used, returned, or quarantined.
(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)